Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer

Diseases of the Colon and Rectum

Volumn 50, Issue 10, 2007, Pages 1585-1593

  Higashiguchi, Takashi ^a   Hotta, Tsukasa ^a   Takifuji, Katsunari ^a   Yokoyama, Shozo ^a   Matsuda, Kenji ^a   Tominaga, Toshiji ^a   Oku, Yoshimasa ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemokine receptor 7; Colorectal cancer; Matrix metalloproteinase 7; Reverse transcriptase polymerase chain reaction; Reversion inducing cysteine rich protein with Kazal motifs; Vascular endothelial growth factor C

Indexed keywords

CHEMOKINE RECEPTOR CCR7; MATRILYSIN; MESSENGER RNA; VASCULOTROPIN C;

AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; GENE EXPRESSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; UNIVARIATE ANALYSIS;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RECEPTORS, CCR7; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 35348837475     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-007-9016-3     Document Type: Article

References (26)

1. Cohen AM, Tremiterra S, Candela F, Theler HT, Sigurdson ER. Prognosis of node positive colon cancer. Cancer 1991;67:1859-61.
2. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-36.
3. Wilson CL, Matrisian LM. Matrilysin. In: Parks WC, Mecham RP, eds. Matrix metalloproteinases. San Diego: Academic Press, 1998:149-84.
4. Adachi Y, Yamamoto H, Itoh F, et al. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 2001;95:290-4.
5. Takahashi C, Akiyama N, Matsuzaki T, Takai S, Kitayama H, Noda M. Characterization of human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Oncogene 1996;12:2137-46.
6. Takeuchi T, Hisanaga M, Nagao M, et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 2004;15:5572-9.
7. Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002;15:2937-41.
8. Kaipanen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-70.
9. Kawakami M, Furuhata T, Kimura Y, et al. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery 2003;133:300-8.
10. UICC. TNM classification of malignant tumors. 4th ed. New York: Springer-Verlag, 1997.
11. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas. Arch Surg 2004;139:188-92.
12. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;45:200-6.
13. Okabe N, Shia F, Nash G, et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 2004;8:1032-40.
14. Masaki T, Muto T. Predictive value of histology at the invasive margin in the prognosis of early invasive colon and rectal cancer. J Gastroenterol 2000;35:195-200.
15. Adachi Y, Yasuda K, Kakisako K, Sato K, Shiraishi N, Kitano S. Histopathologic criteria for local excision of colorectal cancer: multivariate analysis. Ann Surg Oncol 1999;6:385-8.
16. MacDonnel S, Narve M, Coffey R, et al. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinoma. Mor Carcinog 1991;4:527-33.
17. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A. Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancer. Int J Cancer 1993;54:614-8.
18. Yamamoto H, Itoh F, Adachi Y, et al. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 1997;112:1271-7.
19. Senota A, Itoh F, Yamamoto H, Adachi Y, Hinoda Y, Imai K. Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer. Clin Exp Metastasis 1998;16:313-21.
20. Adachi Y, Itoh F, Yamamoto H, et al. Matrix metalloproteinsase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 1998;13:1031-5.
21. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999;59:3313-6.
22. Noda M, Kitayama H, Matsuzaki T, et al. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci USA 1989;86:162-6.
23. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell 1989;56:77-84.
24. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinsase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998;95:13221-6.
25. Sasahara RM, Takahashi C, Noda M. Involvement of Sp1 site in ras mediated downregulation of RECK metastasis suppressor gene. Biochem Biophys Res Commun 1999;264:668-75.
26. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001;107:789-800.